Ciliary neurotrophic factor receptor-related disorder is another name for a very rare genetic disease called cold-induced sweating syndrome (CISS). It mainly affects how the autonomic nervous system works. The autonomic nervous system controls body temperature, sweating, heart rate, breathing, and many “automatic” body functions. In this disorder, these control systems do not work normally, so the person sweats a lot when they are cold, and has many other body problems.
Ciliary neurotrophic factor receptor–related disorder is usually called cold-induced sweating syndrome (CISS) or Crisponi syndrome. It is a very rare genetic condition where the body cannot control temperature in a normal way and many body systems are affected, especially in babies and children. In the newborn period, babies often have very high fevers, feeding problems, stiff muscles, and unusual facial features; later, surviving children develop strong sweating attacks when they are in a cool room, especially on the face, chest, and arms.
This disorder is caused by harmful changes (variants) in two genes called CRLF1 and CLCF1. These genes help build a signaling system that works together with the ciliary neurotrophic factor receptor to guide the growth and function of nerve cells that control sweating, body temperature, and some muscle functions. When both copies of one of these genes do not work (autosomal recessive inheritance), the nerve circuits in the autonomic nervous system do not carry signals properly, and sweating and temperature control become “switched” or unstable.
Doctors now know that “ciliary neurotrophic factor receptor-related disorder,” cold-induced sweating syndrome, and Crisponi syndrome all describe the same disease at different ages. In newborn babies and young infants, the condition is often called Crisponi syndrome and shows with high fever, painful muscle spasms, feeding trouble, and breathing problems. In older children and adults, the same people may instead show strong sweating when they are in a cold place, together with spine and hand changes.
The name “ciliary neurotrophic factor receptor-related” comes from a signaling pathway in the body, called the CNTF–CNTFR pathway. This pathway uses proteins (CNTF, CRLF1, CLCF1, CNTFR) that help nerve cells and other tissues develop and survive. In this disorder, changes (mutations) in some of these pathway genes mean that the signal cannot work properly, and this leads to the autonomic and skeletal problems seen in affected people.
Because this disease is very rare and serious, any person with possible signs should be checked by specialists, usually a pediatric neurologist, clinical geneticist, or autonomic nervous system expert. This explanation is only for general education and cannot replace medical advice from your own doctor.
Other names
Health organizations and genetics groups use several names for this same condition.
-
Cold-induced sweating syndrome (CISS) – This is the most common modern name. It describes the main visible sign in older children and adults: very strong sweating when the person is in a cold environment.
-
Ciliary neurotrophic factor receptor-related disorder – This name highlights that the disease is linked to the signaling pathway of the ciliary neurotrophic factor receptor (CNTFR). Genetic studies show that the main genes involved (CRLF1 and CLCF1) send signals through this receptor.
-
Crisponi syndrome – This name is used mostly for the severe early-life form. Newborns may have muscle spasms that look like neonatal tetanus, high fever, feeding difficulty, and risk of sudden death. Later in life, the same individuals usually develop the typical cold-induced sweating.
-
Sohar–Crisponi syndrome / CS/CISS – These names are used in some studies and rare-disease databases to stress that all these terms describe one disease spectrum with different stages.
Basic biology
The ciliary neurotrophic factor receptor (CNTFR) is a protein on the surface of certain cells, especially nerve cells. It forms a complex with other proteins (gp130 and LIFR) and binds special molecules like CNTF and cardiotrophin-like cytokine (CLCF1). When these molecules attach to the receptor, they send survival and growth signals inside the cell.
In cold-induced sweating syndrome, mutations in CRLF1 or CLCF1 disturb the making of a combined signal that normally activates CNTFR. Because the signal is weak or missing, the developing autonomic nerves and sweat glands do not form or function properly. This leads to abnormal sweating, body temperature control problems, and some muscle and bone changes.
Genetic databases also show that the CNTFR gene itself is associated with cold-induced sweating syndrome and other nervous-system conditions, which supports the idea that this whole pathway is important for the disease.
Types
Researchers and clinicians usually divide ciliary neurotrophic factor receptor-related disorder into a few types, based on which gene is changed.
-
Type 1 – CRLF1-related (CISS1 / Crisponi–CISS1)
In this type, both copies of the CRLF1 gene have disease-causing mutations. CRLF1 helps form a signaling complex with CLCF1 that normally activates CNTFR. When CRLF1 is faulty, the signal cannot be sent well, and autonomic nerves and skeletal structures develop abnormally. Most reported cases of CISS are type 1. -
Type 2 – CLCF1-related (CISS2)
In this type, both copies of the CLCF1 gene have harmful changes. CLCF1 is a ligand that works together with CRLF1 to activate CNTFR. A mutation in CLCF1 also blocks normal signaling and leads to similar clinical features: early severe neonatal symptoms and later cold-induced sweating. Only a small number of families with CISS2 have been described. -
Other possible CNTFR pathway-related cases
Some databases link the CNTFR gene itself to cold-induced sweating syndrome, but clear human cases with proven CNTFR mutations are rare. It is possible that future research will identify additional subtypes involving CNTFR or other pathway genes, but at present, most confirmed patients have CRLF1 or CLCF1 variants.
Causes and contributing factors
The main true cause of this disorder is genetic: changes in genes in the CNTFR signaling pathway. Other items below are risk factors, modifiers, or triggers that can affect how the disease shows in real life.
-
Pathogenic CRLF1 gene mutations
Disease-causing (pathogenic) variants in both copies of the CRLF1 gene are a major cause. These changes stop CRLF1 from helping CLCF1 signal through CNTFR, disturbing autonomic and skeletal development. -
Pathogenic CLCF1 gene mutations
Some families have harmful changes in both copies of the CLCF1 gene. The faulty CLCF1 protein cannot signal correctly to CNTFR, leading to the same disease picture. -
Autosomal recessive inheritance pattern
The disorder follows an autosomal recessive pattern: each parent usually carries one mutated copy but is healthy. A child is affected when they inherit both mutated copies. This pattern explains why the condition often appears in siblings in the same family. -
Consanguinity (parents related by blood)
In some reported families, the parents are related (for example, cousins). When parents share ancestors, they have a higher chance of carrying the same rare variant, increasing risk of autosomal recessive diseases like CISS. -
Disruption of CNTFR signaling
Whether the mutation is in CRLF1, CLCF1, or another pathway gene, the shared mechanism is poor activation of the ciliary neurotrophic factor receptor (CNTFR). This reduces survival and growth signals for autonomic neurons and other tissues. -
Abnormal autonomic nervous system development
With weak CNTFR pathway signaling, parts of the autonomic nervous system, especially those controlling sweating and body temperature, do not develop or wire correctly. This underlying abnormal development causes many of the later symptoms. -
Abnormal sweat gland development and function
Studies suggest that sweat glands and their nerve supply are altered in this condition. Some body regions sweat too much in the cold, while others may not sweat well, showing that sweat gland function is uneven. -
Abnormal hypothalamic temperature regulation
The hypothalamus is the brain area that controls temperature and sweating. Autonomic studies indicate that central (brain) control of temperature is impaired in CISS, contributing to the paradoxical sweating response. -
Skeletal development changes
Many patients develop scoliosis and other bone changes, suggesting that the same pathway that affects nerves may also influence bone growth and spinal alignment. -
Muscle tone and neuromuscular control problems
Abnormal signals to muscles can lead to stiffness, spasms, or low muscle tone at different ages. These neuromuscular issues are part of the overall effect of the gene mutations on the nervous system. -
Possible modifying variants in CNTFR itself
Gene-association resources link CNTFR to cold-induced sweating syndrome and other neurologic traits, suggesting that variations in CNTFR may modify disease risk or severity in some people. -
Possible variants in other pathway genes
Research continues to explore whether other genes in the CNTF/CNTFR pathway or related cytokine loops can cause similar disorders. These genes may not be fully identified yet but are plausible contributors. -
Family history of similar symptoms
Because the disease is genetic, a family history of babies with muscle spasms, unexplained neonatal deaths, or later cold-induced sweating raises the chance that a child might inherit the same condition. -
Founder effect in certain populations
Some mutations appear repeatedly in certain geographic or ethnic groups, suggesting founder mutations. In such groups, the carrier frequency can be higher, making the disease more likely. -
Pregnancy of carrier parents together
When two carriers of a CRLF1 or CLCF1 mutation have children together, each pregnancy has a 25% chance of producing an affected child. This simple genetic risk pattern is a “cause” at the family level. -
Cold environmental exposure as a trigger
Cold air or cold environments do not cause the disease itself, but they trigger the typical sweating attacks in affected people because of the underlying autonomic wiring problem. -
Infections and stress in early life
In infants with CISS/Crisponi syndrome, infections, fever, or other stresses can worsen breathing and feeding problems. These are not genetic causes but can make the disease appear more severe. -
Poor feeding and malnutrition as secondary factors
Feeding difficulty in infancy can lead to poor growth and weakness, which can amplify the effects of the underlying genetic problem. Good nutritional support helps but cannot remove the genetic cause. -
Lack of early diagnosis and supportive care
When the condition is not recognized, the baby may not get adequate respiratory and nutritional support, which can lead to more complications. Again, this is not a root cause but a factor that worsens outcomes. -
Other unknown genetic or environmental modifiers
Because the disease is very rare, scientists believe there may be additional genes and environmental factors that modify how strong or mild the symptoms are, but these have not yet been clearly defined.
Symptoms and signs
-
Profuse sweating in cold environments
The hallmark sign is strong sweating over the chest, face, arms, and trunk when the person is exposed to cold air or cold surroundings. This reaction is the opposite of normal and is why the condition is called cold-induced sweating. -
Abnormal temperature control
People with this disorder often have trouble keeping a stable body temperature. In infancy they may have episodes of very high fever or difficulty keeping warm, even without infection, because the temperature control center is not working properly. -
Neonatal muscle spasms and stiffness (Crisponi picture)
Newborns can show painful-looking muscle contractions, grimacing, and arching of the body that resemble tetanus. These spasms are part of the early form called Crisponi syndrome and can be life-threatening without support. -
Feeding difficulties in infancy
Many babies have trouble sucking, swallowing, or coordinating breathing with feeding. They may choke, cough, or refuse feeds, leading to poor weight gain and the need for special feeding strategies. -
Breathing and respiratory problems
Weakness, abnormal muscle control, and poor coordination can cause breathing difficulties, especially in the first months of life. Some infants may need intensive care or respiratory support during crises. -
Risk of sudden death in the neonatal period
Because of severe hyperthermia, muscle spasms, and breathing problems, some untreated babies with Crisponi/CISS may die suddenly. This makes early recognition and supportive treatment very important. -
Characteristic facial appearance
Many affected people have a typical facial look, such as a wide mouth, full cheeks, and a “grimacing” or tense expression, especially during spasms. These features help experienced doctors suspect the diagnosis. -
Camptodactyly and hand contractures
Bent fingers (camptodactyly), hand contractures, and other limb posture abnormalities are common. These reflect muscle and joint changes that develop with time. -
Scoliosis (curved spine)
Many children develop a side-to-side curve of the spine, called scoliosis. This can slowly worsen with age and may require bracing or surgery for support. -
Autonomic symptoms (blood pressure and heart-rate problems)
Because the autonomic nervous system is affected, patients may have abnormal heart-rate responses, low blood pressure when standing, or other autonomic failures, as shown in special tests. -
Abnormal sweating pattern in other situations
Some people may have little sweating when they are hot, and over-sweating when they are cold, or uneven sweating in different body parts. This mismatch adds to their discomfort and can affect daily life. -
Neuromuscular fatigue and weakness
Patients may feel easily tired, weak, or have poor endurance, especially during illness or physical stress. This may relate to the underlying neuromuscular involvement seen in autonomic studies. -
Sleep problems and discomfort at night
Abnormal sweating and temperature swings can disturb sleep. Children may wake frequently due to feeling too hot, too cold, or uncomfortable from sweating or muscle cramps. -
Psychological and social impact
Older children and adults may feel embarrassed by heavy sweating in cold weather and by their physical appearance (curved spine, finger deformities). This can cause anxiety, low self-confidence, and social withdrawal. -
Chronic pain or discomfort
Bone deformities, muscle contractions, and repeated infections or respiratory problems can lead to chronic pain or discomfort that needs long-term management.
Diagnostic tests
Physical examination tests
-
Complete physical examination and growth review
The doctor does a full exam, checking weight, height, head size, muscle tone, and general appearance, and compares these to normal growth charts. Poor growth, unusual muscle tone, and the typical face may suggest a CNTFR-related disorder and guide further testing. -
Skin, sweating pattern, and temperature observation
The doctor carefully looks at the skin for areas that are very sweaty or very dry, and measures body temperature in different situations. Patients with CISS often show strange sweating patterns, especially when exposed to mild cold during the exam. -
Musculoskeletal and facial examination
The doctor studies the face, hands, and spine for features like grimacing expression, camptodactyly, and scoliosis. These visible signs, combined with history of neonatal crises, strongly support the clinical suspicion of Crisponi/CISS. -
Vital signs in different positions and environments
Heart rate, blood pressure, and breathing are recorded while the patient is lying, sitting, and standing, and sometimes in warm versus cool rooms. Abnormal changes in these vital signs point to autonomic nervous system involvement.
Manual bedside tests
-
Controlled cold-exposure (cold provocation) test
Under safe conditions, the doctor may expose a small skin area or the whole body to mild cold (for example, a cool room or cool air) while watching for sweating. In CISS, even mild cold can trigger strong sweating over the face and upper body, which helps confirm the clinical pattern. -
Orthostatic (postural) blood pressure test
The patient lies down for some minutes, then stands up while blood pressure and heart rate are measured. A strong drop in blood pressure or abnormal heart-rate response suggests autonomic failure, which is part of this disorder. -
Simple exercise or handgrip challenge
The doctor may ask the patient to squeeze a handgrip or walk briefly while monitoring sweating and heart rate. The aim is to see whether sweating and circulation change normally with effort or show the abnormal responses typical of autonomic neuropathy. -
Pupil and eye surface examination
By shining light into the eyes and checking tear production, the doctor can look for abnormal autonomic control of the pupils and tear glands, which often goes along with other autonomic problems in CISS.
Laboratory and pathological tests
-
Basic blood tests (CBC, electrolytes, kidney and liver tests)
Routine blood tests help rule out other causes of fever, poor growth, or weakness (such as infections, anemia, or organ disease). In CISS these basic tests are often normal, which pushes doctors to consider rare genetic causes when symptoms are severe. -
Endocrine and metabolic tests
Thyroid function tests, adrenal hormone levels, and other metabolic tests may be done to exclude endocrine disorders that also affect sweating and temperature. Normal results again support a primary autonomic genetic disorder like CISS rather than a hormone problem. -
Targeted genetic testing for CRLF1
Sequencing of the CRLF1 gene looks for pathogenic variants in both copies. Finding such variants in a person with the typical clinical picture makes the diagnosis of CISS1 very strong. This genetic confirmation also allows accurate family counseling. -
Targeted genetic testing for CLCF1
If CRLF1 testing is negative, sequencing of CLCF1 can detect mutations responsible for CISS2. Although rarer, confirming a CLCF1 mutation proves that the CNTFR pathway is involved in this patient’s disease. -
Extended gene panels including CNTFR pathway genes
Modern labs may use multigene panels for autonomic neuropathy or sweating disorders. These panels can include CRLF1, CLCF1, CNTFR, and other related genes to check for rare or new variants that disturb the same signaling pathway. -
Confirmatory and family carrier testing
Once a causative variant is found in an affected child, parents and siblings can be tested to see who is a carrier and who is affected. This does not change the patient’s condition but is very important for family planning and early diagnosis in future pregnancies.
Electrodiagnostic and autonomic function tests
-
Nerve conduction studies (NCS)
NCS measure how fast and how strong electrical signals travel along sensory and motor nerves. In CISS, results may show features of a hereditary sensory and autonomic neuropathy, helping separate this disorder from purely muscle diseases or central brain problems. -
Autonomic reflex screen (including heart-rate and blood-pressure tests)
An autonomic reflex screen is a group of tests that measure how the heart rate and blood pressure react to deep breathing, the Valsalva maneuver, and changes in body position. In cold-induced sweating syndrome, these tests can show central and peripheral autonomic failure. -
Quantitative sudomotor axon reflex test (QSART) or thermoregulatory sweat test
These tests measure how much and where sweat is produced in response to controlled stimulation or body heating. Patients with CISS have a very abnormal sweat map, with intense sweating in some areas and absent sweating in others, which matches their clinical complaints.
Imaging tests
-
Spine X-rays for scoliosis
Simple X-rays of the spine are used to look for scoliosis and to measure how severe the curve is. In many patients with CISS, scoliosis develops over time, so repeated X-rays help decide when bracing or surgery might be needed. -
Brain and brainstem MRI
MRI of the brain and brainstem is not specific for CISS but helps rule out other structural causes of temperature and autonomic problems, such as tumors or malformations. A normal MRI supports the idea that the problem is mostly at the microscopic or pathway level, as in CNTFR-related disorders. -
Chest imaging (X-ray or CT) for respiratory complications
Chest X-rays or CT scans can show lung infections, scoliosis-related lung restriction, or other breathing complications that are common in severe neonatal and childhood stages. These imaging tests help guide supportive treatment, even though they do not diagnose the genetic disorder itself.
Non-pharmacological treatments
1. Temperature and trigger control
The most basic therapy is careful control of the child’s environment. Families try to avoid sudden exposure to cool air, strong air-conditioning, or moving quickly from a warm room to a cold one, because these changes can trigger very heavy sweating attacks. Using room thermometers and keeping the home at a stable, comfortable temperature helps reduce sudden autonomic stress on the body.
2. Layered clothing and protective wear
Children and adults can wear light layers of clothing so that they can quickly adjust to changes in temperature. Thin cotton layers allow sweat to evaporate while still protecting from cold air that might trigger sweating. Gloves, scarves, and head coverings are useful outside in cool weather, because the face and upper body are common sites of sweating in this disorder.
3. Careful heat management in infancy
In newborns and infants, episodes of dangerous high fever are common, so parents and staff must check body temperature often. Simple cooling methods, such as tepid sponging, fans, and removing extra clothes, are used very gently to avoid swinging between overheating and cold-triggered sweating. This balanced approach aims to keep core temperature close to normal without over-cooling.
4. Specialized feeding support
Feeding problems and risk of aspiration are major issues in early life. Thickened feeds, careful positioning, slow feeding, and sometimes feeding tubes (nasogastric or gastrostomy) are used to keep the baby safe and well-nourished. Good nutrition supports growth, muscle strength, and immune function, which can reduce complications from infections and poor weight gain.
5. Swallowing and speech therapy
Speech and swallowing therapists teach safe swallowing techniques and exercises to improve mouth and throat muscle control. Simple drills, such as slow chewing, chin-tuck posture while drinking, and practicing speech sounds, can lower the risk of choking and aspiration pneumonia. These therapies also help reduce drooling and improve communication, which is important for school and social participation.
6. Physiotherapy for posture and contractures
Regular physiotherapy keeps joints flexible and muscles as strong as possible. Stretching, gentle strengthening exercises, and posture training reduce the risk of fixed contractures in hands and feet and can slow the progression of spine deformity. Therapists also teach safe transfers, sitting positions, and breathing exercises that support lung function in children with kyphoscoliosis.
7. Orthopedic bracing for the spine
When the spine starts to curve, doctors may prescribe braces or corsets to support the back. Bracing does not cure the curve, but it can slow progression and improve balance and breathing in some children. It is usually combined with physiotherapy and regular X-ray monitoring to plan if and when surgery is needed.
8. Respiratory support and airway care
Babies with Crisponi features can have breathing difficulties during fevers or spasms, and older children may have restricted lung function from spinal deformity. Non-invasive supports such as oxygen, high-flow nasal cannula, or bilevel positive airway pressure may be used during acute illness or sleep. Chest physiotherapy and careful positioning help clear secretions and prevent pneumonia.
9. Pain management with physical methods
Muscle contractions, joint stiffness, and back pain are common. Warm packs, gentle massage, stretching, and relaxation breathing can ease pain without extra medicines. Regular, low-impact movement prevents stiffness from becoming worse and can reduce the frequency of painful spasms.
10. Psychological counseling and family support
Living with a rare, unpredictable disorder is stressful for the child and family. Psychologists and social workers can help families cope with anxiety, worry about fevers or sweating attacks, and feelings of isolation. Simple tools such as coping skills training, school counseling, and peer-support groups improve quality of life and help parents make complex medical decisions.
11. Educational planning and school accommodations
Children may need extra time to cool down or change clothes after sweating episodes, flexible seating for back pain, and help during physical education. An individualized education plan can include rest breaks, access to water and temperature-controlled rooms, and understanding from teachers. This support reduces absenteeism and helps the child keep up academically.
12. Genetic counseling for the family
Because this disorder is autosomal recessive, each parent is usually a healthy carrier, and each pregnancy has a one-in-four chance of being affected. Genetic counseling explains these risks in simple language and discusses options like carrier testing of relatives, prenatal diagnosis, or preimplantation genetic testing. This information helps families plan future pregnancies and understand the cause of the disease.
13. Infection prevention and vaccination
Children with serious early-life illness and feeding problems are more vulnerable to infections. Staying up to date with routine vaccines, including influenza and pneumonia vaccines when recommended, reduces the risk of severe lung infections. Good hand hygiene, dental care, and avoiding smoke exposure also protect overall health.
14. Nutritional counseling and high-energy diets
Because feeding is hard and energy use is high during fevers and sweating attacks, children can become underweight. Dietitians can design high-calorie, nutrient-dense diets with enough protein, healthy fat, vitamins, and minerals, sometimes using special formulas or supplements. Good nutrition supports growth, bone health, and immune function.
15. Gentle, tailored physical activity
With the guidance of doctors and physiotherapists, many older children can take part in light activities such as walking, swimming in warm pools, or adapted sports. These activities are planned to avoid extremes of cold or heat and to prevent exhaustion. Regular, safe movement helps maintain muscle strength, mood, and social contact.
16. Home monitoring and emergency plans
Families are taught how to check temperature, breathing, and general condition during fevers or sweating attacks. Simple emergency plans explain when to give antipyretics, when to cool or warm the child, and when to call an ambulance. Having a written plan lowers panic and speeds up care in urgent situations.
17. Sleep hygiene and positioning
Good sleep is hard when a child sweats, shivers, or has pain at night. Using breathable bedding, slightly raising the head of the bed, and keeping the room at a stable comfortable temperature can reduce night attacks. Calm bedtime routines and sometimes supportive pillows for the back help improve sleep quality.
18. Occupational therapy for daily living skills
Occupational therapists help children learn self-care skills like dressing, bathing, and feeding in ways that respect their limited strength and posture. They can suggest adapted grips, clothing styles, or bathroom aids to make home life easier. This reduces dependence and improves self-confidence.
19. Rare-disease support networks
Connecting with rare-disease organizations and online groups gives families access to shared experiences, resources, and up-to-date research information. These communities can also help families find specialist centers, clinical trials, or experts with experience in Crisponi/CISS. Feeling less alone is itself an important part of holistic care.
20. Regular follow-up in multidisciplinary clinics
Best care usually comes from a team including genetics, neurology, pulmonology, orthopedics, physiotherapy, nutrition, and psychology. Regular visits allow early detection of spine progression, lung problems, or new symptoms, and allow the treatment plan to be adjusted over time. This team approach is strongly recommended in expert reviews of this syndrome.
Drug treatments
Important: No medicine should be started, stopped, or dosed without a specialist doctor. The drugs below are based on limited case reports and general pharmacology data, not on large trials in this very rare disease.
1. Clonidine (oral tablets or solution)
Clonidine is an alpha-2 adrenergic agonist that acts in the brain to reduce sympathetic nerve activity. GeneReviews and case reports describe clonidine as the first-line drug to reduce cold-triggered sweating in CISS, with starting doses around 0.05–0.1 mg twice daily and slow increases as needed under close monitoring. Its main purposes are to lessen sweating attacks and calm autonomic over-activity, but side effects can include low blood pressure, dry mouth, and drowsiness.
2. Clonidine plus amitriptyline combination
Some experts use clonidine together with the antidepressant amitriptyline, especially when clonidine alone only partly controls sweating or when there is associated pain or sleep disturbance. Amitriptyline is a tricyclic antidepressant that modulates serotonin and norepinephrine and can also reduce neuropathic pain and improve sleep. Usual adult doses for depression range from 25–150 mg at night, but for autonomic symptoms doctors often use much lower starting doses to limit side effects like dry mouth, constipation, and heart rhythm changes.
3. Moxonidine
Moxonidine is another central imidazoline receptor agonist that lowers sympathetic outflow and is reported as helpful for cold-induced sweating in some case series. It is not approved by the FDA in the United States, so dosing follows European hypertension guidelines, often starting at low doses and slowly increasing while checking blood pressure and heart rate. Doctors may consider it when clonidine is not tolerated or is not fully effective.
4. Amitriptyline alone (low dose)
In some patients, low-dose amitriptyline at night is used mainly for pain control, sleep quality, and anxiety management rather than sweating directly. Its mechanism is modulation of pain processing in the central nervous system and mild sedation. Even at low doses (for example 10–25 mg at bedtime in adults), doctors must watch for side effects like dizziness, weight gain, and heart rhythm changes, especially in people with scoliosis or breathing problems.
5. Baclofen
Baclofen is a GABA-B agonist used to treat spasticity in many neurological disorders, and it can help reduce painful muscle spasms and abnormal postures in some CISS patients, although direct data are limited. Typical adult dosing for spasticity starts at 5 mg three times daily and slowly increases up to a maximum of about 80 mg per day, always under careful supervision to avoid excessive weakness, sleepiness, or withdrawal reactions.
6. Gabapentin
Gabapentin is an anticonvulsant and neuropathic pain modulator that binds to calcium channels in nerve cells. It is sometimes used off-label to treat neuropathic pain, burning sensations, or discomfort related to muscle contractions in neuromuscular disorders. Usual adult doses for neuropathic pain range from about 900–3,600 mg per day in divided doses, started low and titrated slowly; common side effects include dizziness, sleepiness, and swelling of ankles.
7. Pregabalin
Pregabalin, related to gabapentin, is also used for neuropathic pain and can help if patients have chronic pain or anxiety related to their condition. It reduces excessive nerve firing by binding to alpha-2-delta subunits of calcium channels. Standard adult dosing for neuropathic pain often begins at 150 mg per day divided into two or three doses, with careful titration to a maximum of 300–600 mg per day depending on kidney function and tolerance; side effects include dizziness, weight gain, and peripheral edema.
8. Botulinum toxin A injections for focal hyperhidrosis (very selected cases)
For people with very focal, disabling sweating in small areas, such as the face or underarms, injections of botulinum toxin type A have been used in other forms of hyperhidrosis to temporarily block sweat gland nerve signals. Evidence in CISS is extremely limited, but the theoretical purpose is to reduce local sweating where it causes skin damage or major social problems. The effect is temporary (months), and risks include muscle weakness and spread of toxin effects, so this option must only be considered by experts familiar with botulinum toxin in neurologic conditions.
9. Antipyretics (paracetamol/acetaminophen, ibuprofen)
During acute fever episodes in infancy, standard fever medicines such as acetaminophen or ibuprofen are often used to lower temperature and reduce discomfort. These drugs work by blocking prostaglandin production, which lowers the body’s set-point temperature. Doses follow usual pediatric or adult guidelines based on weight, and side effects are the same as in other children, such as liver strain with too much acetaminophen or stomach irritation with ibuprofen.
10. Short-term sedatives or muscle relaxants in intensive care
In severe neonatal crises with high fever, stiff muscles, or breathing problems, short-acting sedatives or muscle relaxants may be used in the intensive care unit. These medicines help control spasms, reduce metabolic demand, and allow safe ventilation, but they are not long-term treatments for the syndrome. Their use is highly specialized and always balanced against risks like suppressed breathing.
Because this is a very rare disease, there are not 20 separate, well-proven drugs specifically for ciliary neurotrophic factor receptor-related disorder. Most medicines are used off-label to control symptoms, and the clearest published evidence supports clonidine, clonidine plus amitriptyline, or moxonidine for cold-induced sweating, combined with supportive care.
Dietary molecular supplements
These supplements do not cure the genetic defect. They may support general nerve, muscle, and bone health. Always ask a doctor or dietitian before starting them.
1. Vitamin D
Vitamin D helps the body absorb calcium and supports bone and muscle function. Studies in different populations show that correcting vitamin D deficiency can improve muscle strength and reduce falls, although very high doses may be harmful. Typical adult maintenance doses are 600–2,000 IU per day, adjusted by blood levels; dosing in children depends on age and weight.
2. Calcium
Calcium is essential for bones and muscle contraction. Children with reduced mobility or feeding problems are at risk of weak bones and fractures, so dietitians often recommend meeting age-appropriate daily calcium intake through foods or supplements. Dose is usually given in milligrams of elemental calcium per day, split with meals, and must be balanced with vitamin D.
3. Omega-3 fatty acids (fish oil or algae oil)
Omega-3 fatty acids (EPA and DHA) are important for brain and nerve cell membranes and have anti-inflammatory effects. Reviews suggest omega-3s may support neuroprotection and muscle health in several neurologic conditions, although data are not specific to CISS. Common supplemental doses in adults range from 500–1,000 mg of combined EPA/DHA daily, but exact amounts should be chosen with medical advice, especially if there is a bleeding risk.
4. B-complex vitamins
B vitamins, especially B1, B6, B9, and B12, are important for energy metabolism and nerve function. In chronic illness or poor intake, low levels may worsen fatigue and nerve symptoms. Typical supplements provide amounts close to or slightly above the daily recommended intake; very high doses of some B vitamins, particularly B6, can themselves damage nerves, so medical guidance is needed.
5. Magnesium
Magnesium participates in nerve signaling, muscle relaxation, and energy production. Some forms, like magnesium threonate, are of special interest for brain and synapse health, but evidence is still emerging. Supplement doses often range from 100–400 mg per day in adults from all sources; excessive dosing can cause diarrhea or low blood pressure.
6. Creatine
Creatine acts as an energy buffer in muscle and brain cells. Studies in neuromuscular and aging populations suggest creatine can support muscle performance when combined with physical therapy. Typical adult doses are 3–5 grams per day after an optional loading phase, but kidney function and hydration must be monitored.
7. Antioxidant vitamins C and E
Oxidative stress can damage cells, and antioxidant vitamins may help buffer this damage. Some neuromuscular and neurodegenerative research explores antioxidant support, but clear benefits are not proven for CISS. Doses usually stay within standard daily ranges to avoid side effects like stomach upset or, at very high doses of vitamin E, bleeding risk.
8. Multivitamin-mineral supplement
A simple daily multivitamin-mineral product can cover small gaps in intake caused by picky eating, feeding difficulties, or special formulas. The goal is not high pharmacologic doses but steady coverage of common nutrients like iron, zinc, and trace elements. Products should be age-appropriate and chosen with a clinician to avoid overlap with other supplements.
9. Probiotics
Probiotics support gut microbiome balance, which can be disturbed by frequent antibiotics, feeding tubes, or stress. While not specific to CISS, better gut health may help overall immunity, digestion, and tolerance of feeding regimens. Doses vary by product and strain; evidence is strongest for certain strains in diarrhea and antibiotic-associated gut problems.
10. Protein-rich oral nutrition supplements
High-protein, high-calorie oral formulas or shakes can be considered “molecular” nutrition support because they offer concentrated amino acids and nutrients. They are useful when solid food intake is low or feeding is slow. Amount and type should be adjusted by a dietitian based on weight, growth, and kidney function.
Regenerative, immune-modulating and stem-cell-related approaches
Right now, there are no approved stem cell or gene-editing drugs for ciliary neurotrophic factor receptor–related disorder. Research teams have created induced pluripotent stem cell (iPSC) lines from patients with Crisponi/CISS2 to study how the CRLF1/CLCF1 pathway affects temperature regulation and nerve development in the lab. These cell models may guide future regenerative or gene-targeted therapies, but they are still experimental and not available as clinical treatments.
Experimental ideas under discussion in the scientific community include gene replacement or repair for CRLF1 or CLCF1, biologic drugs that mimic or correct the missing CNTF-related signaling, and broader neurotrophic factor therapies. At present, these are theoretical or early preclinical concepts, and any “immunity-boosting” or “regenerative” drugs used in routine care should be understood as general supportive medicines, not cures for this specific genetic defect. Families should be very cautious of unregulated “stem cell clinics” that claim to cure rare genetic disorders without strong evidence.
Surgical treatments
1. Spinal fusion for kyphoscoliosis
As children grow, many develop severe kyphoscoliosis that can limit breathing and cause pain. When bracing and physiotherapy are not enough, orthopedic surgeons may perform spinal fusion with rods and screws to straighten and stabilize the spine. The goal is to protect lung function, reduce pain, and improve sitting and standing balance, even though full normal alignment is not always possible.
2. Tendon release or soft-tissue surgery for contractures
Babies and children can develop tight joints in their hands, feet, and other areas due to muscle contractions. In selected cases, surgeons may lengthen tendons or release tight tissues to improve range of motion and function. These surgeries are usually combined with intensive physiotherapy and splinting after the operation.
3. Gastrostomy tube placement
For infants and children with severe feeding problems and risk of aspiration, a gastrostomy tube (G-tube) may be placed directly into the stomach. This procedure allows safe delivery of fluids, calories, and medicines while reducing choking and weight loss. Over time, a G-tube can improve growth, energy, and caregiver stress.
4. Tracheostomy and airway surgery (selected severe cases)
In rare, extremely severe neonatal cases with repeated airway obstruction or need for long-term mechanical ventilation, a tracheostomy may be needed to secure the airway. This is usually considered only after careful evaluation in an intensive-care setting and is accompanied by strong family support and training. The purpose is to make breathing safer and more stable during critical periods.
5. Endoscopic thoracic sympathectomy (ETS) for focal hyperhidrosis – very rare and controversial
ETS is a surgery where parts of the sympathetic nerve chain in the chest are cut or clipped to reduce sweating in the upper body. It is used in some forms of focal hyperhidrosis, but it is controversial because it can cause side effects like compensatory sweating in other areas. In CISS, ETS would only be considered in exceptional cases after failure of medical therapy and with full understanding of risks.
Key prevention strategies
Because this is a genetic disorder, we cannot prevent it completely, but we can prevent or reduce complications:
-
Genetic counseling and carrier testing for parents and at-risk relatives before future pregnancies.
-
Prenatal or preimplantation genetic diagnosis in families with known CRLF1 or CLCF1 variants, when available and desired.
-
Avoiding extreme cold exposure and rapid temperature shifts to lower sweating attacks.
-
Avoiding overheating and dehydration, especially in infants with high fevers.
-
Routine vaccinations and infection control to reduce lung and general infections.
-
Regular orthopedic monitoring to detect spinal curvature early and start bracing or therapy.
-
Early feeding and swallowing assessment to prevent aspiration and failure to thrive.
-
Good nutrition and bone health support with adequate calcium, vitamin D, and calories.
-
Written emergency plans for fevers and breathing problems, shared with schools and caregivers.
-
Regular follow-up at a specialist center to adjust treatment as the child grows.
When to see a doctor
Families should seek urgent medical care if a child with this disorder has very high fever, trouble breathing, blue lips, repeated choking during feeds, severe back pain, or sudden change in alertness. These signs can point to serious complications such as pneumonia, sepsis, or spinal cord compression and need immediate evaluation.
A specialist review is also needed when sweating attacks become more frequent or intense, when blood pressure or heart rate seem very low with medicines like clonidine, or when the spine curve appears to be worsening quickly. Even if the child seems stable, regular planned visits to genetics, neurology, and orthopedics are important to keep treatment up to date with new research and to adjust doses safely.
What to eat and what to avoid
Helpful to eat (5 ideas)
-
Energy-dense meals and snacks with healthy fats (olive oil, nut butters if safe, avocado) and protein help children who burn extra calories from fevers and sweating keep up their weight.
-
Calcium- and vitamin-D-rich foods like dairy products or fortified plant milks support bone health in children with limited mobility.
-
Fish or fortified sources of omega-3 fatty acids a few times per week can support general brain and nerve health.
-
Plenty of fruits and vegetables provide antioxidants and fiber, which support immune function and gut health.
-
Adequate fluids (water, oral rehydration solutions if needed) are important during sweating attacks or fevers to prevent dehydration.
Best to limit or avoid (5 ideas)
-
Very cold drinks and icy foods can sometimes trigger shivering and sweating and may be uncomfortable in sensitive children.
-
Highly processed, high-sugar snacks give “empty” calories without nutrients and can worsen weight and blood sugar control.
-
Caffeine-containing drinks (cola, energy drinks, strong tea) can stimulate the heart and nervous system and may interact with medicines used for autonomic symptoms.
-
Very salty foods can worsen blood pressure swings in some patients, especially when combined with drugs like clonidine, so salt intake should be balanced as advised by doctors.
-
Alcohol and tobacco exposure (for older patients and the household) can damage heart, lungs, and nerves and should be avoided to protect long-term health.
Frequently asked questions (FAQs)
1. Is ciliary neurotrophic factor receptor–related disorder the same as Crisponi syndrome?
Yes. Today most experts believe that Crisponi syndrome in infancy and cold-induced sweating syndrome in childhood and adulthood are different stages of the same genetic disorder affecting the CRLF1/CLCF1 pathway and CNTF receptor signaling.
2. How is this disorder inherited?
It follows an autosomal recessive pattern, which means a child must receive one non-working gene copy from each parent. Parents are usually healthy carriers with no symptoms, but each pregnancy has a 25% chance of being affected.
3. Can we test for the genes?
Yes. Molecular testing of CRLF1 and CLCF1 is available in many genetic laboratories and can confirm the diagnosis, help with family planning, and guide carrier testing in relatives. Results should always be discussed with a geneticist or genetic counselor.
4. Will my child outgrow the disease?
Children do not “outgrow” the genetic change, but many of the severe infant symptoms improve over time. Later, other problems such as sweating attacks and spine curvature become more important, so the disease changes with age rather than fully disappearing.
5. What is the life expectancy?
Many babies with very severe Crisponi features die in the first months of life from infections or fever crises, but those who survive infancy can often live into adulthood with careful supportive care. Exact life expectancy is not known because the condition is very rare, and outcomes vary widely.
6. Is there a cure or gene therapy now?
There is no approved cure or gene therapy yet. Research using patient-derived stem cells is helping scientists understand the disease better and could support future genetic or regenerative treatments, but these are not ready for routine clinical use.
7. Why does cold air cause sweating instead of shivering alone?
In this disorder, the autonomic nervous system misreads cold signals and sends mixed commands to the sweat glands and muscles. Instead of only shivering, the body releases sweat inappropriately, especially on the upper body and face, leading to “paradoxical” cold-induced sweating.
8. Which medicines have the best evidence for treating sweating attacks?
The most clearly described medicines are clonidine, clonidine combined with amitriptyline, and moxonidine, which all reduce sympathetic nerve activity. Small studies and case reports show reduced sweating with these drugs, but doses and responses vary, and careful monitoring for low blood pressure and sedation is essential.
9. Are there big risks with clonidine?
Clonidine can cause low blood pressure, slow heart rate, sleepiness, and dry mouth, especially when doses are increased too quickly or stopped suddenly. For this reason, specialists start with very low doses, increase slowly, and teach families never to stop the drug abruptly without medical supervision.
10. Can normal vaccines be given?
Most children with this disorder follow the routine vaccination schedule, and vaccines are important to prevent serious infections. Any special adjustments should be discussed with the child’s pediatrician and specialists, especially if there are breathing or immune problems from other causes.
11. Will my child need surgery on the spine?
Some children develop severe kyphoscoliosis that cannot be controlled with braces and therapy. In those cases, spinal fusion surgery may be recommended to stabilize the spine and protect lung function. Regular orthopedic reviews help decide on the best timing and type of surgery.
12. Can diet alone control the disease?
No. Diet and supplements cannot fix the underlying genetic cause. However, good nutrition supports growth, bone strength, and immunity, which helps the child handle infections, surgeries, and daily physical stress better. Nutrition is one important piece of a larger care plan.
13. Are sports and physical activity safe?
Many older children can do gentle, supervised activities as long as they avoid extreme cold, overheating, and over-exertion. Physiotherapists can help design safe exercise programs that protect the spine and lungs while supporting strength and confidence.
14. Where can we find experts?
Because this is a very rare disorder, care is usually concentrated in major pediatric neurology or genetics centers and rare-disease clinics. Patient organizations and online rare-disease databases can help families locate clinicians with experience in Crisponi/CISS.
15. Is online information reliable?
Many websites give only brief or outdated information about this ultra-rare condition. The most reliable sources are peer-reviewed reviews such as GeneReviews, MedlinePlus Genetics, and specialist neurology or genetics textbooks and articles, plus guidance from your own medical team. Families should be careful with blogs or commercial sites that promise cures.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: February 09, 2025.
